Publication bias in dermatology systematic reviews and meta-analyses

Journal of Dermatological Science

Volumn 82, Issue 2, 2016, Pages 69-74

  Atakpo, Paul ^a   Vassar, Matt ^a  

^a OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES   (United States)

Author keywords

Dermatology; Meta analysis; Publication bias; Systematic review

Indexed keywords

TOPICAL AGENT;

ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DERMATOLOGY; DRUG EFFICACY; HUMAN; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TINEA CORPORIS; TINEA CRURIS; VERRUCA VULGARIS; LITERATURE; META ANALYSIS (TOPIC); STANDARDS;

DERMATOLOGY; HUMANS; META-ANALYSIS AS TOPIC; PUBLICATION BIAS; REVIEW LITERATURE AS TOPIC;

EID: 84959253048     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2016.02.005     Document Type: Article

References (39)

1. Abuabara K., Freeman E.E., Dellavalle R. The role of systematic reviews and meta-analysis in dermatology. J. Investig. Dermatol. 2012, 132:e2.
2. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000, 283:2008-2012. 10.1001/jama.283.15.2008.
3. Reddi A., Prescott L., Doney E., et al. The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology. J. Evid. Based Med. 2013, 6:236-242.
4. Chi C.C., Wang S.H., Wojnarowska F., Kirtschig G., Davies E., Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst. Rev. 2015, 10:CD007346.
5. Onishi A., Furukawa T.A. Publication bias is underreported in systematic reviews published in high-impact-factor journals: metaepidemiologic study. J. Clin. Epidemiol. 2014, 67:1320-1326.
6. Rothstein H., Sutton A.J., Borenstein M. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments 2005, Wiley, Chichester, England.
7. Easterbrook P., Gopalan R., Berlin J., Matthews D. Publication bias in clinical research. Lancet 1991, 337:867-872.
8. Hopewell S., Loudon K., Clarke M.J., Oxman A.D., Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Protoc. Cochrane Database Syst. Rev. 2009.
9. Song F.H., Loke Y. Publication bias: what is it? How do we measure it? How do we avoid it?. Open Access J. Clin. Trials 2013, 71.
10. J.P.T Higgins, S. Green (eds.), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from . http://www.cochrane-handbook.org.
11. Montori V.M., Wilczynski N.L., Morgan D., Haynes R.B. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. BMJ 2005, 330:68.
12. Kepes S., Banks G.C., McDaniel M., Whetzel D.L. Publication bias in the organizational sciences. Organ. Res. Methods 2012, 15:624-662.
13. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
14. McDaniel M.A. Cumulative meta-analysis as a publication bias method. Annual Meeting of the Society for Industrial and Organizational Psychology 2009.
15. Cohen J. Statistical Power Analysis for the Behavioural Sciences 1977, Saunders College Publishing/Harcourt Brace, New York.
16. Guerrieri-Gonzaga A., Gandini S. Vitamin D and overall mortality. Pigment Cell Melanoma Res. 2012, 26:16-28.
17. Nast A., Jacobs A., Rosumeck S., Werner R.N. Efficacy and safety of systemic long-term treatments for moderate-to-severe psoriasis: a systematic review and meta-analysis. J. Investig. Dermatol. 2015, 135:2641-2648.
18. Ma C., Harskamp C.T., Armstrong E.J., Armstrong A.W. The association between psoriasis and dyslipidaemia: a systematic review. Br. J. Dermatol. 2013, 168:486-495.
19. Kwok C.S., Holland R., Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br. J. Dermatol. 2011, 165:233-246.
20. Ensslin C.J., Rosen A.C., Wu S., Lacouture M.E. Pruritus in patients treated with targeted cancer therapies: systematic review and meta-analysis. J. Am. Acad. Dermatol. 2013, 69:708-720.
21. Minkis K., Garden B.C., Wu S., Pulitzer M.P., Lacouture M.E. The risk of rash associated with ipilimumab in patients with cancer: a systematic review of the literature and meta-analysis. J. Am. Acad. Dermatol. 2013, 69:e121-e128.
22. Samarasekera E.J., Sawyer L., Wonderling D., Tucker R., Smith C.H. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br. J. Dermatol. 2013, 168:954-967.
23. van Zuuren E.J., Fedorowicz Z., El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br. J. Dermatol. 2015, 172:616-641.
24. Rotta I., Ziegelmann P.K., Otuki M.F., Riveros B.S., Bernardo N.L.M.C., Correr C.J. Efficacy of topical antifungals in the treatment of dermatophytosis. JAMA Dermatol. 2013, 149:341.
25. Rota M., Negri E., Pelucchi C., La Vecchia C. Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors. Br. J. Dermatol. 2014, 171:658-659.
26. Schmitt J., Zhang Z., Wozel G., Meurer M., Kirch W. Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br. J. Dermatol. 2008, 159:513-526.
27. Schmitt J., Rosumeck S., Thomaschewski G., Sporbeck B., Haufe E., Nast A. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br. J. Dermatol. 2014, 170:274-303.
28. Olsen J.R., Gallacher J., Finlay A.Y., Piguet V., Francis N.A. Quality of life impact of childhood skin conditions measured using the children's dermatology life quality index (CDLQI): a meta-analysis. Br. J. Dermatol. 2015.
29. Rourke L., Oberholtzer S., Chatterley T., Brassard A. Learning to detect, categorize, and identify skin lesions. JAMA Dermatol. 2015, 151:293.
30. Schram M.E., Tedja A.M., Spijker R., Bos J.D., Williams H.C., Spuls P.I. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br. J. Dermatol. 2010, 162:964-973.
31. Bonitsis N.G., Tatsioni A., Bassioukas K., Ioannidis J.P.A. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermat. 2011, 64:245-257.
32. Lee Y.H., Scharnitz T.P., Muscat J., Chen A., Gupta-Elera G., Kirby J.S. Laboratory monitoring during Isotretinoin therapy for acne. JAMA Dermatol. 2016, 152:35.
33. Chen L., Li Z., Yu Y., Wang Z., Zhang H. Smoking is inversely related to cutaneous malignant melanoma: results of a meta-analysis. Br. J. Dermatol. 2015, 173:1540-1543.
34. Valentine J., Belum V.R., Duran J., et al. Incidence and risk of xerosis with targeted anticancer therapies. J. Am. Acad. Dermatol. 2015, 72:656-667.
35. Crawford F., Harris R., Williams H.C. Are placebo-controlled trials of creams for athlete's foot still justified?. Br. J. Dermatol. 2008, 159:773-779.
36. Rotta I., Sanchez A., Gonçalves P.R., Otuki M.F., Correr C.J. Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. Br. J. Dermatol. 2012, 166:927-933.
37. Ioannidis J.P., Trikalinos T.A. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 2007, 176:1091-1096.
38. Villar J., Piaggio G., Carroli G., Donner A. Factors affecting the comparability of meta-analyses and largest trials results in perinatology. J. Clin. Epidemiol. 1997, 50:997-1002.
39. Moher D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009, 151:264.